Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.0%

1 terminated/withdrawn out of 49 trials

Success Rate

90.9%

+4.4% vs industry average

Late-Stage Pipeline

12%

6 trials in Phase 3/4

Results Transparency

10%

1 of 10 completed trials have results

Key Signals

7 recruiting1 with results

Enrollment Performance

Analytics

N/A
18(54.5%)
Phase 2
7(21.2%)
Phase 4
5(15.2%)
Phase 1
2(6.1%)
Phase 3
1(3.0%)
33Total
N/A(18)
Phase 2(7)
Phase 4(5)
Phase 1(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (49)

Showing 20 of 49 trials
NCT07713992Not ApplicableNot Yet Recruiting

Efficacy and Safety of Mazdutide in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Nonalcoholic Fatty Liver Disease Previously Treated With Semaglutide

Role: collaborator

NCT07714577Not ApplicableNot Yet Recruiting

Investigator-Initiated Study of BBM-C101 Injection in Subjects With HPV16/18 Infection

Role: lead

NCT07707973Phase 2Not Yet Recruiting

Nimotuzumab Combined With the Stupp Regimen for Postoperative Residual Glioblastoma

Role: lead

NCT07707622Enrolling By Invitation

Sepsis in Critically Ill Patients

Role: collaborator

NCT07697937Phase 2Recruiting

YH02 Injection for Intra-tumor Injection Therapy in Advanced Solid Tumors With Unresponsive or Failure-Treated Cases

Role: lead

NCT07651722Not ApplicableRecruiting

Effect of Liposomal Bupivacaine TAPB Combined With Oxycodone PCIA on Postoperative Gastrointestinal Recovery in Patients Undergoing Major Abdominal Surgery

Role: lead

NCT07653321Enrolling By Invitation

Acute Kidney Injury in Critically Ill Patients

Role: collaborator

NCT07650851Not ApplicableNot Yet Recruiting

Clinical Study on the Efficacy and Safety of Nalfurafine Hydrochloride Orally Disintegrating Tablets in Treating Pruritus in Patients Undergoing Maintenance Hemodialysis

Role: collaborator

NCT07577934Not ApplicableRecruiting

Efficacy of Liposomal Bupivacaine for Transversus Abdominis Plane Block

Role: lead

NCT07409298Not ApplicableEnrolling By Invitation

Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor Therapy

Role: collaborator

NCT03664518Phase 2Completed

to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection

Role: collaborator

NCT03384277Phase 4Completed

Trial of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab

Role: collaborator

NCT07157631Not ApplicableRecruiting

Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial

Role: collaborator

NCT06716658Phase 2Recruiting

JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

Role: collaborator

NCT07173244Not Yet Recruiting

A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors

Role: lead

NCT05998759Phase 2Recruiting

Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia

Role: collaborator

NCT05339425Completed

Chinese Osteoporotic Fracture Registration Network Platform

Role: collaborator

NCT06598228Completed

Acute Kidney Injury and Recovery Mode in Pediatric Liver Transplantation

Role: lead

NCT03800160Enrolling By Invitation

Greater China Metabolic and Bariatric Surgery Database

Role: collaborator

NCT06317597Phase 4Enrolling By Invitation

Efficacy of Short Time Intervals in Split-Dose Bowel Preparation of Oral Sulfate Solution for Colonoscopy

Role: collaborator